June 27, 2023 Comments Off on New patent for Boehringer Ingelheim drug JENTADUETO Posted in: Patent Added Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post New patent for Boehringer Ingelheim drug JENTADUETO a…
June 27, 2023 Comments Off on New patent for Boehringer Ingelheim drug TRADJENTA Posted in: Patent Added Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are ten patents…
The post New patent for Boehringer Ingelheim drug TRADJENTA appeare…